SCHEMBL30836047

SCHEMBL30836047

CC(C)(C)OC(=O)N1CC(C#Cc2ccc(C(F)(F)F)c[n+]2N)C1.Cc1cc(C)c(S(=O)(=O)[O-])c(C)c1

nearest known ligand 0.36

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 4/20 0.36
▸ MCL1 Q07820 1/20 0.36
▸ ALDH2 P05091 1/20 0.35
▸ STS P08842 1/20 0.35
▸ RORC P51449 1/20 0.34
▸ TGFBR1 P36897 1/20 0.33
▸ TACR1 P25103 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HSD11B1 P28845 2/20 0.32
▸ NR1H2 P55055 1/20 0.32
▸ P2RY14 Q15391 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30835941 0.89 EPHX2 (0.36) EPHX2MCL1ALDH2STSRORC
SCHEMBL30835991 0.89 RORC (0.41) MCL1ALDH2STSRORCTGFBR1
SCHEMBL20512225 0.84 CYP1A2 (0.34) EPHX2MAPT
SCHEMBL30835950 0.76 RORC (0.39) ALDH2STSRORCTACR1MAPT
SCHEMBL31556571 0.69 RORC (0.43) STSRORCTACR1MAPT
SCHEMBL28658591 0.69 CYP1A2 (0.40) EPHX2MCL1MAPT
SCHEMBL30835998 0.69 SYK (0.43) ALDH2STSRORCTACR1MAPT
SCHEMBL30835993 0.68 GPR119 (0.48) ALDH2STSRORCTGFBR1TACR1
SCHEMBL28711089 0.68 EPHX2 (0.40) EPHX2STSRORC
SCHEMBL22462783 0.67 AR (0.40) EPHX2ALDH2RORCTACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587424-A1 YAP/TAZ-TEAD ONCOPROTEINS INHIBITORS Bridgene Biosciences, Inc. (US) 2025-07-23 — — EP disclosed
CN-119894866-A YAP/TAZ-TEAD oncoprotein inhibitors 布里奇恩生物科学公司 2025-04-25 — — CN disclosed
WO-2024059317-A1 YAP/TAZ-TEAD ONCOPROTEINS INHIBITORS BRIDGENE BIOSCIENCES, INC. (US) 2024-03-21 — — WO disclosed
Send feedback